BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8221519)

  • 1. Histopathologic patterns of erythema migrans and borrelial lymphocytoma.
    de Koning J
    Clin Dermatol; 1993; 11(3):377-83. PubMed ID: 8221519
    [No Abstract]   [Full Text] [Related]  

  • 2. Electron microscopy of Langerhans cells and Borrelia burgdorferi in Lyme disease patients.
    Hulínská D; Barták P; Hercogová J; Hancil J; Basta J; Schramlová J
    Zentralbl Bakteriol; 1994 Jan; 280(3):348-59. PubMed ID: 8167429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Borrelial erythema of the face].
    de Heller-Milev M; Peter O; Panizzon RG; Laffitte E
    Ann Dermatol Venereol; 2008 Dec; 135(12):852-4. PubMed ID: 19084697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
    Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
    J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico.
    Gordillo-Pérez G; Torres J; Solórzano-Santos F; de Martino S; Lipsker D; Velázquez E; Ramon G; Onofre M; Jaulhac B
    Emerg Infect Dis; 2007 Oct; 13(10):1556-8. PubMed ID: 18258006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.
    Zore A; Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Pikelj A; Jurca T; Logar M; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):606-9. PubMed ID: 12422609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of peripheral and central biopsy sites for the isolation of Borrelia burgdorferi sensu lato from erythema migrans skin lesions.
    Jurca T; Ruzić-Sabljić E; Lotric-Furlan S; Maraspin V; Cimperman J; Picken RN; Strle F
    Clin Infect Dis; 1998 Sep; 27(3):636-8. PubMed ID: 9770166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borrelial Lymphocytoma in Adult Patients.
    Maraspin V; Nahtigal Klevišar M; Ružić-Sabljić E; Lusa L; Strle F
    Clin Infect Dis; 2016 Oct; 63(7):914-21. PubMed ID: 27334446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions.
    Strle F; Cheng Y; Cimperman J; Maraspin V; Lotric-Furlan S; Nelson JA; Picken MM; Ruzic-Sabljic E; Picken RN
    Clin Infect Dis; 1995 Aug; 21(2):380-9. PubMed ID: 8562748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Borrelia burgdorferi in the skin.
    Aberer E; Kersten A; Klade H; Poitschek C; Jurecka W
    Am J Dermatopathol; 1996 Dec; 18(6):571-9. PubMed ID: 8989928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans.
    Mitchell PD; Reed KD; Vandermause MF; Melski JW
    Am J Clin Pathol; 1993 Jan; 99(1):104-7. PubMed ID: 8422007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of erythema migrans in Borrelia afzelii and Borrelia garinii infections.
    Carlsson SA; Granlund H; Jansson C; Nyman D; Wahlberg P
    Scand J Infect Dis; 2003; 35(1):31-3. PubMed ID: 12685881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema chronicum migrans in Suzhou, China.
    Song F
    Arch Dermatol; 1993 Jun; 129(6):793-4. PubMed ID: 8507094
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and species typing of Lyme borreliosis spirochaetes from UK patients with erythema migrans.
    Robertson J; Murdoch S; Foster L; Green S
    Eur J Epidemiol; 1999 May; 15(5):499-500. PubMed ID: 10442477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema migrans--influence of posture. Case report.
    Oksi J; Hietarinta M; Viljanen MK
    APMIS; 2000 Oct; 108(10):649-51. PubMed ID: 11200819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
    Wienecke R; Schlüpen EM; Zöchling N; Neubert U; Meurer M; Volkenandt M
    J Invest Dermatol; 1995 Jan; 104(1):23-6. PubMed ID: 7798636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of B-cell chronic lymphocytic leukemia associated with Borrelia burgdorferi infection showing a marginal zone B-cell lymphoma-like infiltrate.
    Kash N; Fink-Puches R; Cerroni L
    Am J Dermatopathol; 2011 Oct; 33(7):712-5. PubMed ID: 21946761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular erythema migrans.
    Goldberg NS; Forseter G; Nadelman RB; Schwartz I; Jorde U; McKenna D; Holmgren D; Bittker S; Montecalvo M; Wormser GP
    Arch Dermatol; 1992 Nov; 128(11):1495-8. PubMed ID: 1444504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients.
    Kuiper H; Cairo I; Van Dam A; De Jongh B; Ramselaar T; Spanjaard L; Dankert J
    Br J Dermatol; 1994 Apr; 130(4):466-72. PubMed ID: 8186111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.